tiprankstipranks
Alligator Bioscience AB (GB:0RK9)
:0RK9
UK Market

Alligator Bioscience AB (0RK9) Income Statement

Compare
0 Followers

Alligator Bioscience AB Income Statement

Last quarter (Q4 2022), Alligator Bioscience AB's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Alligator Bioscience AB's net income was $-53.25M. See Alligator Bioscience AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 11.77M$ 11.14M$ 11.52M$ 11.55M$ 5.90M
EBITDA
$ -180.99M$ -130.36M$ -131.46M$ -198.15M$ -144.14M
Operating Income
$ -192.30M$ -141.36M$ -144.04M$ -213.17M$ -152.18M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -193.40M$ -141.74M$ -143.30M$ -210.11M$ -150.04M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Alligator Bioscience AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis